Who Owns Procter & Gamble? Biggest Shareholders and Recent Insider Trades

Nikko Henson7 minute read
Reviewed by: Thomas Richmond
Last updated Jan 20, 2026

Procter & Gamble (PG) started in 1837 when William Procter, a candlemaker, and James Gamble, a soapmaker, formed a partnership in Cincinnati. The two brothers-in-law built a business selling candles and soap to households along the Ohio River.

Nearly two centuries later, P&G operates one of the world’s largest portfolios of consumer brands. Tide, Gillette, Pampers, Crest, Bounty, and Charmin reach billions of households across more than 180 countries. The company generates roughly $85 billion in annual revenue, with gross margins above 50%, reflecting its pricing power and brand strength built over generations.

The stock has declined about 7.4% over the past year, from an all-time high near $179 to around $145 today. The pullback reflects concerns over volume growth and margin pressure as consumers trade down to cheaper alternatives. P&G now has a market capitalization of approximately $340 billion and offers a dividend yield of approximately 2.9%, supported by decades of uninterrupted dividend growth.

What makes P&G particularly interesting to institutional investors is its defensive positioning. The company sells products that people buy regardless of economic conditions. Toothpaste, diapers, laundry detergent, and razors are not discretionary purchases. That stability, combined with strong free cash flow and a long track record of returning capital to shareholders, has made P&G a core holding for pension funds, sovereign wealth funds, and income-focused portfolios worldwide.

Once closely tied to long-term retail ownership, P&G is now heavily dominated by global asset managers and retirement systems, reflecting its status as a defensive anchor in institutional portfolios.

Understanding who owns Procter & Gamble and how that ownership is shifting reveals where conviction lies as the company navigates pricing pressure, volume headwinds, and changing consumer behavior, as this article examines in detail.

Who Are P&G’s Top Shareholders?

Procter & Gamble's largest shareholders
Procter & Gamble’s largest shareholders. #TIKR 

See whether Procter & Gamble’s top shareholders are buying or selling today >>>

Procter & Gamble makes consumer goods across categories like fabric care, grooming, baby care, and oral care, with brands that dominate shelves worldwide. Ownership of the company is dominated by large index funds, keeping PG closely tied to global equity flows. Alongside them, active managers made noticeable adjustments last quarter.

  • Vanguard Group: 233.6M shares (9.99%), $33.8B. Trimmed 1.7M (-0.70%).
  • BlackRock Institutional Trust: 121.4M shares (5.20%), $17.6B. Added 3.6M (+3.04%).
  • State Street Investment Management: 100.6M shares (4.31%), $14.5B. Added 371K (+0.37%).
  • Geode Capital Management: 60.7M shares (2.60%), $8.8B. Added 1.3M (+2.12%).
  • Norges Bank: 32.0M shares (1.37%), $4.6B. Added 727K (+2.32%).
  • T. Rowe Price Associates: 25.0M shares (1.07%), $3.6B. Increased 1.5M (+6.24%).
  • Morgan Stanley Smith Barney: 21.5M shares (0.92%), $3.1B. Trimmed 785K (-3.52%).
  • Fidelity Management & Research: 19.8M shares (0.85%), $2.9B. Added 498K (+2.58%).
  • Northern Trust Investments: 17.8M shares (0.76%), $2.6B. Reduced 147K (-0.82%).
  • Charles Schwab Investment Management: 17.7M shares (0.76%), $2.6B. Added 273K (+1.57%).
  • BofA Global Research: 16.9M shares (0.72%), $2.4B. Cut 18K (-0.10%).
  • State Farm Insurance: 16.8M shares (0.72%), $2.4B. Trimmed 10K (-0.06%).

The most notable move came from BlackRock Institutional Trust, which added 3.6 million shares, a 3.04% increase. That addition stands out given the stock’s 19% decline over the past year, suggesting BlackRock sees value at current levels.

T. Rowe Price also made a significant move, raising its stake by 6.24% with the addition of 1.5 million shares. Geode Capital increased its position by 2.12%, adding 1.3 million shares, while Norges Bank, Norway’s sovereign wealth fund, added 727,000 shares, up 2.32%.

On the other side, Morgan Stanley Smith Barney reduced its holdings by 3.52%, cutting 785,000 shares. Vanguard trimmed its position slightly by 0.70%, while Northern Trust reduced by 0.82%.

Index giants like Vanguard, BlackRock, and State Street keep P&G stable as a core portfolio holding. The additions from BlackRock, T. Rowe Price, and Geode suggest some active managers see opportunity in the pullback, while Morgan Stanley’s reduction may reflect profit-taking or concern about near-term margin pressure.

Track the top shareholders of over 50,000 global stocks (It’s free) >>>

P&G’s Recent Insider Trades

Procter & Gamble's recent insider transactions
Procter & Gamble’s recent insider transactions. (TIKR)

Insider activity gives a peek into how company leaders may be managing their personal exposure. At Procter & Gamble, recent transactions have favored selling over buying.

While insider sales can happen for many reasons that are not directly tied to business outlook, the broad participation of multiple executives makes the trend worth noting for investors.

Here are recent insider transactions:

  • Jon R. Moeller (CEO): Sold approximately 1,400 shares across multiple transactions at $144.35 in early December 2025. The sales appear relatively modest in size and are likely tied to compensation.
  • Shailesh Jejurikar (Officer and Director): Sold roughly 380 shares at $144.35, spread across several transactions on December 3, 2025.
  • Ma. Fatima Francisco (Officer): Sold 148 shares at $144.35 in early December 2025.
  • Marc S. Pritchard (Officer): Sold 95 shares at $144.35 on December 3, 2025.
  • Victor Javier Aguilar Moses: Sold 55 shares in early December 2025.

Additionally, several directors received small stock grants in early December, including Craig Arnold (215 shares), Joseph Jimenez (341 shares), Christine M. McCarthy (269 shares), Christopher J. Kempczinski (260 shares), Ashley McEvoy (215 shares), and Robert Jones Portman (54 shares). These appear to be routine director compensation rather than open-market purchases.

The selling activity appears spread across the leadership team at prices near $144, which is below the stock’s 52-week high of $180. The transactions appear modest in size and may reflect diversification or pre-set trading plans. No meaningful open-market insider buying was reported, suggesting management is not rushing to add at current price levels.

While sales on their own do not necessarily signal weakness, the absence of insider buying may leave investors cautious about the stock’s near-term valuation.

See recent insider trade data for over 50,000 global stocks (It’s free) >>>

What the Ownership & Insider Trade Data Tell Us

Procter & Gamble remains a global portfolio staple, with ownership anchored by index giants like Vanguard, BlackRock, and State Street. That base of passive and institutional capital helps keep the stock steady, while active managers have shown mixed signals.

BlackRock Institutional Trust’s 3.04% increase stands out as a meaningful addition, suggesting the firm sees value after the stock’s 19% pullback. T. Rowe Price raised its stake by 6.24%, while Geode Capital added 2.12%. On the other hand, Morgan Stanley Smith Barney trimmed its position by 3.52%, and Vanguard reduced its position by 0.70%.

On the insider side, activity has leaned toward selling across multiple executives. Sales occurred at $144.35, well below the stock’s $180 high from late 2024. These moves may simply reflect diversification or scheduled plans, but the absence of meaningful open-market buying stands out. It could indicate that leadership does not view the current price as a clear bargain.

For investors, the takeaway is that P&G remains a durable, dividend-paying compounder. Some institutions are adding on weakness, but the lack of insider buying and mixed positioning among active managers suggests caution about committing more capital at current levels.

Value Any Stock in Under 60 Seconds with TIKR

With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.

All it takes is three simple inputs:

  1. Revenue Growth
  2. Operating Margins
  3. Exit P/E Multiple

If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.

From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.

Estimate a company’s fair value instantly (Free with TIKR) >>>

Related Posts

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required